Residency · Durham, NC
Sponsored by Duke University Hospital
Omalizumab for the Treatment of Multiple Food Allergies.
The New England journal of medicine · 2024 · 270 citations · Edwin Kim
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study.
Lancet (London, England) · 2022 · 283 citations · Edwin Kim, Wesley Burks
International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022 · 151 citations · Benjamin Wright
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
The Journal of allergy and clinical immunology · 2024 · 68 citations · Edwin Kim, Yamini Virkud, Wesley Burks
Management of Food Allergies and Food-Related Anaphylaxis.
JAMA · 2024 · 59 citations ·
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
The New England journal of medicine · 2023 · 105 citations · Edwin Kim, Wesley Burks
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Lancet (London, England) · 2023 · 108 citations · Rebecca Buckley
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
The Journal of allergy and clinical immunology · 2023 · 115 citations · Talal Mousallem, Niraj Patel